Shorepoint Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.4M Buy
+35,714
New +$3.28M 0.68% 54
2025
Q1
$3.15M Buy
35,040
+343
+1% +$30.7K 0.71% 56
2024
Q4
$2.77M Buy
34,697
+707
+2% +$61.2K 0.63% 59
2024
Q3
$3.06M Buy
33,990
+1,495
+5% +$126K 0.7% 58
2024
Q2
$2.56M Buy
32,495
+798
+3% +$65.4K 0.6% 66
2024
Q1
$2.76M Buy
31,697
+385
+1% +$32.9K 0.68% 57
2023
Q4
$2.58M Buy
31,312
+4,983
+19% +$380K 0.69% 62
2023
Q3
$2.06M Buy
26,329
+614
+2% +$51.4K 0.61% 61
2023
Q2
$2.27M Sell
25,715
-305
-1% -$26.3K 0.64% 58
2023
Q1
$2.1M Buy
26,020
+878
+3% +$71.6K 0.6% 59
2022
Q4
$1.95M Sell
25,142
-1,055
-4% -$85.5K 0.54% 61
2022
Q3
$2.12M Sell
26,197
-2,424
-8% -$218K 1.01% 43
2022
Q2
$2.57M Sell
28,621
-4,759
-14% -$482K 1.09% 43
2022
Q1
$3.7M Buy
33,380
+610
+2% +$64.4K 1.55% 27
2021
Q4
$3.39M Buy
32,770
+384
+1% +$44.5K 1.38% 30
2021
Q3
$4.06M Buy
+32,386
New +$4.19M 1.82% 20
2021
Q1
$3.16M Buy
26,741
+1,941
+8% +$227K 1.69% 24
2020
Q4
$2.9M Sell
24,800
-4
-0% -$440 1.61% 27
2020
Q3
$2.58M Buy
24,804
+5,463
+28% +$549K 1.6% 28
2020
Q2
$1.77M Buy
19,341
+4,127
+27% +$396K 1.16% 38
2020
Q1
$1.37M Buy
15,214
+708
+5% +$75.3K 1.1% 34
2019
Q4
$1.65M Sell
14,506
-342
-2% -$37.5K 0.94% 44
2019
Q3
$1.61M Sell
14,848
-560
-4% -$58.4K 0.95% 43
2019
Q2
$1.5M Buy
15,408
+1,730
+13% +$158K 0.86% 48
2019
Q1
$1.25M Buy
+13,678
New +$1.22M 0.71% 51

Other funds holding MDT

Shorepoint Capital Partners's MDT Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in Medtronic (MDT) in Q3 2025: 35,714 shares worth $3.4M. The stake represents 0.68% of the portfolio and ranks #54 among its holdings. This is a return to the name: Shorepoint Capital Partners previously reported a position in MDT as recently as Q1 2025.

Shorepoint Capital Partners first reported a position in MDT in Q1 2019 and has held it in 25 quarters since. The position peaked at $4.06M in Q3 2021. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Shorepoint Capital Partners held 35,714 shares of Medtronic worth $3.4M as of Q3 2025.
  • Medtronic was a new Shorepoint Capital Partners position in Q3 2025.
  • Medtronic made up 0.68% of Shorepoint Capital Partners's portfolio in Q3 2025, its #54 holding.
  • Shorepoint Capital Partners first reported a position in Medtronic in Q1 2019 and has held it in 25 quarters since.
  • Shorepoint Capital Partners's Medtronic position peaked at $4.06M in Q3 2021.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.